CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 Pfreundschuh.2011
%A Pfreundschuh, Michael
%A Kuhnt, Evelyn
%A Trümper, Lorenz
%A Österborg, Anders
%A Trneny, Marek
%A Shepherd, Lois
%A Gill, Devinder S.
%A Walewski, Jan
%A Pettengell, Ruth
%A Jaeger, Ulrich
%A Zinzani, Pier-Luigi
%A Shpilberg, Ofer
%A Kvaloy, Stein
%A de Nully Brown, Peter,
%A Stahel, Rolf
%A Milpied, Noel
%A López-Guillermo, Armando
%A Poeschel, Viola
%A Grass, Sandra
%A Loeffler, Markus
%A Murawski, Niels
%D 2011
%J The Lancet Oncology
%K IMISE-Publikationen
%N 11
%P 1013–1022
%T CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
%V 12
@article{Pfreundschuh.2011,
added-at = {2014-10-14T15:28:08.000+0200},
author = {Pfreundschuh, Michael and Kuhnt, Evelyn and Trümper, Lorenz and Österborg, Anders and Trneny, Marek and Shepherd, Lois and Gill, Devinder S. and Walewski, Jan and Pettengell, Ruth and Jaeger, Ulrich and Zinzani, Pier-Luigi and Shpilberg, Ofer and Kvaloy, Stein and {de Nully Brown, Peter} and Stahel, Rolf and Milpied, Noel and López-Guillermo, Armando and Poeschel, Viola and Grass, Sandra and Loeffler, Markus and Murawski, Niels},
biburl = {https://www.bibsonomy.org/bibtex/287a64c7334f66ade4571344aacf36b9c/drtester},
interhash = {c640adfa358b5763ff10eedfbbb58f02},
intrahash = {87a64c7334f66ade4571344aacf36b9c},
journal = {The Lancet Oncology},
keywords = {IMISE-Publikationen},
number = 11,
pages = {1013–1022},
timestamp = {2014-10-14T15:28:08.000+0200},
title = {CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group},
volume = 12,
year = 2011
}